Position paper ANMCO: Stati Generali ANMCO 2024 – Nell’era della cardiologia di precisione, una riflessione su equilibrio tra contenimento dei costi e innovazione
Cardiovascular diseases continue to be the leading cause of death worldwide, with ischemic heart disease remaining the primary cause among cardiovascular conditions; as is well known, it is closely linked to LDL cholesterol levels, now identified as the "cause" of atherosclerotic plaque development and not just a risk factor. The recent introduction of increasingly powerful lipid-lowering drugs makes it more realistic today to achieve the desired LDL targets, and the evolution of therapeutic strategies allows for more personalized care by tailoring treatments to the specific profile of each patient. There are also high expectations for therapies, currently under evaluation, aimed at other potential targets contributing to atherosclerotic disease, such as lipoprotein(a) and interleukin-6. However, these new and potent therapies also have a significant economic impact, making it essential for scientific societies to thoughtfully consider how to manage resources to ensure equitable care. Likely, the use of digital tools can support a balanced and cost-effective management approach.
Authors
- Alessandro Navazio (ORCID: https://orcid.org/0000-0001-8417-7783)
- Attilio Iacovoni (ORCID: https://orcid.org/0000-0003-0347-6672)
- Vittorio Pascale (ORCID: https://orcid.org/0000-0003-0465-4709)
- Fabiana Lucà (ORCID: https://orcid.org/0000-0002-5369-5382)
- Claudio Bilato (ORCID: https://orcid.org/0000-0003-3474-0579)
- Emanuele Tizzani
- Furio Colivicchi (ORCID: https://orcid.org/0000-0001-7187-2234)
- Domenico Gabrielli (ORCID: https://orcid.org/0000-0003-3392-0527)
- Federico Nardi (ORCID: https://orcid.org/0000-0002-7743-2587)
- Pietro Scicchitano (ORCID: https://orcid.org/0000-0003-0471-0053)
- Leonardo De Luca (ORCID: https://orcid.org/0000-0002-8552-1272)
- Giovanna Geraci (ORCID: https://orcid.org/0000-0003-0092-8717)
- Carmine Riccio (ORCID: https://orcid.org/0000-0003-0160-3674)
- Marco Corda (ORCID: https://orcid.org/0000-0003-2365-8596)
- Fabrizio Oliva (ORCID: https://orcid.org/0000-0002-5827-996X)
- Massimo Milli (ORCID: https://orcid.org/0000-0003-4811-6224)
- Maria Grimaldi
- Massimo Di Marco (ORCID: https://orcid.org/0000-0002-4423-5202)
Institutions
- Altera (United States) (US)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
- AULSS 2 Marca Trevigiana (IT)
- Ospedale San Filippo Neri (IT)
- Azienda ospedaliera "Bianchi-Melacrino-Morelli" (IT)
- Azienda Sanitaria di Firenze (IT)
- Nuovo Ospedale San Giovanni di Dio (IT)
- Ospedale Sant Antonio (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Ospedale di Santo Spirito (IT)
- Presidio Ospedaliero (IT)
- Azienda Ospedaliera S.Maria (IT)
- Ospedale Generale Regionale Francesco Miulli (IT)
- Azienda Ospedaliera Pugliese Ciaccio (IT)
- Ospedale Sant'Anna (IT)
- Policlinico San Matteo Fondazione (IT)
- Ospedale degli Infermi (IT)
- Azienda Usl Toscana Centro (IT)
- Azienda Ospedaliera G. Brotzu (IT)
Publication Details
- Journal
- Giornale italiano di cardiologia
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1714/4542.45436
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00